Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications

Completed

Conditions studied: HIV Infections

In brief

The purpose of this study is to observe the effects of certain anti-HIV medications on mitochondrial activity and fat cell death. This study will enroll participants from another study, ACTG A5202, who are on treatment regimens that do not include zidovudine, stavudine, or other thymidine-containing anti-HIV medications.

Key facts

Study ID

NCT00433992

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

56

Starts

2006-04-01

Expected to finish

2009-12-01

Last updated by the study team

2017-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-infected
• Enrolling in ACTG A5202 and its metabolic substudy ACTG A5224

You may not qualify if…

• Bleeding problems
• Cannot undergo fat biopsies
• Require aspirin anytime in the 7-day period prior to each biopsy

Where it is running

• Case School of Medicine — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.